PRE 14A XBRL

PROXY STATEMENT

Company: TherapeuticsMD, Inc.
Filed: October 24, 2025
Period of Report: October 24, 2025
Accession Number: 0001213900-25-102166

View Document ↗ View on SEC.gov ↗